![]() |
市場調查報告書
商品編碼
2081257
數位治療遊戲市場預測(2034 年)—按治療領域、年齡層、技術、應用、最終用戶和地區分類的全球分析Digital Therapeutic Gaming Market Forecasts to 2034 - Global Analysis By Therapeutic Area, Age Group, Technology, Application, End User and By Geography |
||||||
全球數位治療遊戲市場預計到 2026 年將達到 10 億美元,並在預測期內以 20.0% 的複合年成長率成長,到 2034 年將達到 43 億美元。
數位治療遊戲是指基於電子遊戲的介入措施,這些措施經過臨床驗證,旨在治療特定的認知、心理或行為症狀。這些遊戲利用自適應難度、沉浸式故事情節和獎勵機制等引人入勝的機制,來靶向與注意力不足過動症(ADHD)、憂鬱症和焦慮症等疾病相關的潛在神經通路。本質上,它們將實證心理策略(如認知行為療法 (CBT))與互動娛樂相結合,提供了一種易於接受、風險低且高度吸引人的治療方式,患者可以積極參與其中。
日益惡化的精神健康危機
全球精神健康障礙(包括憂鬱症、焦慮症和注意力不足過動症)盛行率的不斷上升,顯著增加了對便利且引人入勝的替代療法的需求。傳統療法面臨著巨大的容量限制,因為精神健康專業人員無法滿足患者日益成長的需求。數位治療遊戲提供了一種擴充性的解決方案,能夠惠及服務不足的人群,例如偏遠或農村地區的居民。醫療保健系統越來越認知到,與持續用藥相比,數位干預具有更高的成本效益。患者,尤其是熟悉互動技術的年輕一代,越來越傾向於非藥物療法,這正在推動這種方法的普及。
臨床療效要求
數位治療遊戲產品必須透過嚴格的隨機對照試驗來證明其臨床療效,才能獲得監管部門的批准和醫生的認可。這一漫長而昂貴的檢驗過程對小規模開發商而言構成了巨大的市場准入障礙。在許多醫療保健系統中,不明確的報銷機制限制了病患的就醫途徑和商業性可行性。傳統醫療機構對遊戲應用治療價值的質疑也延緩了在臨床環境中的應用。此外,產品上市後需要持續產生療效證據,這會產生大量的營運成本,使得盈利面臨挑戰。
處方箋數位藥物的擴張
處方箋出現為將數位治療遊戲融入標準治療方案鋪平了道路。美國、歐洲和日本的法規結構已建立明確的核准流程,以檢驗臨床可靠性。製藥公司正擴大與數位療法開發商合作,以引人注目的數位干預措施來補充傳統藥物療法。支付者和保險公司正在製定專門針對處方數位療法的報銷模式,以擴大患者的用藥範圍。與電子健康記錄的整合使醫療服務提供者能夠無縫地進行處方和監測。
健康應用市場顛覆
大量缺乏臨床檢驗的通用型健康和心理健康應用程式的湧現,正在擾亂市場秩序,並削弱專業人士對合法數位療法的信心。消費者難以區分基於實證的治療性遊戲和缺乏臨床嚴謹性的娛樂性健康應用程式。不同司法管轄區監管執法力度的不一致,使得不合格產品得以在價格上競爭。無效健康應用程式帶來的負面體驗,正在使人們對整個數位療法領域產生懷疑。應用商店的分類限制也使得區分經過臨床檢驗的產品變得更加困難。
新冠疫情嚴重擾亂了傳統的面對面心理健康和復健服務,加速了對遠端醫療替代方案的需求,包括數位治療遊戲。醫療服務提供者迅速採用包含數位介入措施的遠端醫療模式,以在封鎖期間維持患者的參與度。儘管數位療法的臨床試驗在招募參與者方面面臨挑戰,但遠端檢驗方法的可行性已得到證實。疫情後,醫療系統維護了擴展的數位健康基礎設施,支持數位療法的持續應用。這場危機使患者與醫療服務提供者之間的數位健康互動成為常態,降低了接受數位治療遊戲的門檻。
在預測期內,認知行為療法 (CBT) 遊戲細分市場預計將成為規模最大的細分市場。
由於強力的臨床證據支持認知行為療法 (CBT) 遊戲在治療憂鬱症、焦慮症和創傷後壓力症候群 (PTSD) 方面的有效性,預計在預測期內,CBT 遊戲領域將佔據最大的市場佔有率。醫療保健提供者擴大將基於 CBT 的數位干預措施作為輕度至中度症狀的一線治療方案。該領域受益於主要市場中已建立的保險報銷機制。龐大的精神健康障礙目標人口創造了巨大的商業性機會。與雇主健康計劃的整合正在將其應用範圍從臨床領域擴展到預防醫學領域。
預計在預測期內,成人細分市場將呈現最高的複合年成長率。
在預測期內,成人市場預計將呈現最高的成長率,這主要得益於旨在改善認知功能、管理心理健康和進行神經復健的數位治療遊戲解決方案的日益普及。壓力、焦慮、憂鬱症、注意力不足過動症和與老齡化相關的認知衰退的日益普遍,促使成人將經臨床驗證的遊戲平台作為輔助治療工具。此外,遠端醫療的普及、遊戲化驅動的治療技術的進步以及將數位療法融入個人化護理方案的趨勢,都在加速這一細分市場的成長。對能夠提高治療依從性和改善長期健康結果的、具有吸引力的數據驅動型乾預措施的需求不斷成長,預計將進一步鞏固成人市場在數位治療遊戲市場中的地位。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於美國食品藥物管理局(FDA)針對處方箋位療法所製定的監管路徑,該路徑正在建立清晰的商業性框架。美國在該領域處於領先地位,擁有對數位健康新創公司的大量創業投資投資以及成熟的保險報銷談判能力。強大的製藥業正在促進傳統藥物研發公司與數位療法創新者之間的夥伴關係。加拿大先進的數位健康政策正在推動成熟治療性介入的快速普及。微軟、蘋果和Meta等大型科技公司正大力投資健康類遊戲的研發。
在預測期內,亞太地區預計將呈現最高的複合年成長率。這主要是由於該地區人口大規模,但傳統心理健康服務取得管道有限,從而催生了擴充性的數位化替代方案的需求。中國、日本和韓國的政府數位健康舉措正優先發展由科技驅動的醫療服務。該地區的行動遊戲文化正在逐漸消除人們對治療性遊戲的偏見。不斷成長的醫療保健支出和日益壯大的中產階級正在擴大高階數位健康產品的目標市場。本地開發者正在創作符合當地文化、能引起患者共鳴的治療內容。
According to Stratistics MRC, the Global Digital Therapeutic Gaming Market is accounted for $1.0 billion in 2026 and is expected to reach $4.3 billion by 2034 growing at a CAGR of 20.0% during the forecast period. Digital Therapeutic Gaming represents clinically validated, video game-based interventions engineered to treat specific cognitive, psychological, or behavioral conditions. These games utilize engaging mechanics like adaptive difficulty, immersive narratives, and reward loops to target underlying neural pathways associated with disorders like ADHD, depression, or anxiety. Essentially, they merge evidence-based psychological strategies like Cognitive Behavioral Therapy (CBT) with interactive entertainment, delivering an accessible, low-risk, and highly engaging medical treatment format that patients eagerly stick with.
Mental health crisis escalation
Rising global prevalence of mental health disorders, including depression, anxiety, and ADHD, creates substantial demand for accessible and engaging treatment alternatives. Traditional therapy faces significant capacity constraints with insufficient mental health professionals to meet growing patient needs. Digital therapeutic games offer scalable solutions that can reach underserved populations in remote and rural areas. Healthcare systems increasingly recognize the cost-effectiveness of digital interventions compared to ongoing pharmacological treatments. Patient preference for non-pharmaceutical therapeutic options drives adoption, particularly among younger demographics comfortable with interactive technology.
Clinical validation requirements
Digital therapeutic gaming products must demonstrate clinical efficacy through rigorous randomized controlled trials to gain regulatory approval and physician acceptance. The lengthy and expensive validation process creates significant barriers to market entry for smaller developers. Reimbursement pathways remain unclear in many healthcare systems, limiting patient access and commercial viability. Skepticism among traditional healthcare providers regarding the therapeutic value of gaming applications slows clinical adoption. The need for ongoing evidence generation post-launch adds substantial operational costs that challenge profitability.
Prescription digital therapeutics expansion
The emergence of prescription digital therapeutics as a recognized medical category creates formal pathways for digital therapeutic gaming integration into standard care protocols. Regulatory frameworks in the United States, Europe, and Japan establish clear approval processes that validate clinical credibility. Pharmaceutical companies increasingly partner with digital therapeutic developers to complement traditional drug therapies with engaging digital interventions. Payers and insurers develop reimbursement models specifically for prescribed digital treatments, expanding patient access. Integration with electronic health records enables seamless prescribing and monitoring by healthcare providers.
Wellness app market confusion
The proliferation of general wellness and mental health applications without clinical validation creates market confusion that undermines professional confidence in legitimate digital therapeutics. Consumers struggle to distinguish evidence-based therapeutic games from recreational wellness applications lacking clinical rigor. Regulatory enforcement inconsistencies across jurisdictions enable substandard products to compete on price. Negative experiences with ineffective wellness applications generate skepticism toward the entire digital therapeutic category. App store categorization limitations make differentiation challenging for clinically validated products.
The COVID-19 pandemic severely disrupted traditional in-person mental health and rehabilitation services, accelerating demand for remote therapeutic alternatives, including digital therapeutic gaming. Healthcare providers rapidly adopted telehealth models that incorporated digital interventions to maintain patient engagement during lockdown periods. Clinical trials for digital therapeutics faced enrollment challenges but demonstrated the feasibility of remote validation approaches. Post-pandemic, healthcare systems maintain an expanded digital health infrastructure that supports continued digital therapeutic adoption. The crisis normalized digital health interactions among patients and providers, reducing barriers to digital therapeutic gaming acceptance.
The cognitive behavioral therapy games segment is expected to be the largest during the forecast period
The cognitive behavioral therapy games segment is expected to account for the largest market share during the forecast period, due to strong clinical evidence supporting efficacy for depression, anxiety, and PTSD treatment. Healthcare providers increasingly prescribe CBT-based digital interventions as first-line treatments for mild to moderate conditions. The segment benefits from established reimbursement pathways in major markets. Large addressable populations for mental health conditions create substantial commercial opportunities. Integration with employer wellness programs expands beyond clinical settings into preventive care applications.
The adults segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the adults segment is predicted to witness the highest growth rate, driven by the increasing adoption of digital therapeutic gaming solutions for cognitive enhancement, mental health management, and neurological rehabilitation. Rising prevalence of stress, anxiety, depression, attention disorders, and age-related cognitive decline is encouraging adults to utilize clinically validated gaming platforms as complementary therapeutic tools. Furthermore, growing acceptance of remote healthcare, advancements in gamified treatment technologies, and expanding integration of digital therapeutics into personalized care programs are accelerating segment growth. The demand for engaging, data-driven interventions that improve treatment adherence and long-term health outcomes is expected to further strengthen the adults segment within the Digital Therapeutic Gaming Market.
During the forecast period, the North America region is expected to hold the largest market share, due to FDA regulatory pathways for prescription digital therapeutics that establish clear commercial frameworks. The United States leads with substantial venture capital investment in digital health startups and mature reimbursement negotiation capabilities. Strong pharmaceutical industry presence facilitates partnerships between traditional drug developers and digital therapeutic innovators. Canada's progressive digital health policies support the rapid adoption of validated therapeutic interventions. Major technology companies, including Microsoft, Apple, and Meta, invest heavily in health-focused gaming research and development.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to large populations with limited access to traditional mental health services creating demand for scalable digital alternatives. Government digital health initiatives in China, Japan, and South Korea prioritize technology-enabled care delivery. Mobile gaming culture in the region reduces stigma associated with therapeutic game adoption. Rising healthcare expenditure and growing middle-class populations expand addressable markets for premium digital health products. Local developers create culturally adapted therapeutic content that resonates with regional patient populations.
Key players in the market
Some of the key players in Digital Therapeutic Gaming Market include Akili Interactive Labs Inc., DeepWell Digital Therapeutics Inc., Arcade Therapeutics Inc., Neuroracer Inc., MindMaze SA, Brainlab AG, SAY IT Labs Inc., Barron Associates Inc., PlayNice Institute, SPARX New Zealand, Microsoft Corporation, Nintendo Co. Ltd., Sony Group Corporation, Apple Inc. and Meta Platforms Inc..
In May 2026, Akili Interactive Labs Inc. received FDA clearance for an expanded pediatric ADHD treatment indication, enabling prescription digital therapeutic gaming for adolescents aged 13 through 17.
In April 2026, MindMaze SA launched a virtual reality stroke rehabilitation platform with real-time motion tracking and adaptive difficulty algorithms for clinical and home-based therapy programs.
In March 2026, Microsoft Corporation partnered with leading European healthcare providers to integrate Xbox adaptive controller technology into physical rehabilitation programs for patients with mobility limitations.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.